Evercore ISI upgraded Novocure (NVCR) to Outperform from In Line with a price target of $30, up from $18, heading into the Panova trial readout ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.27% of ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...
Key economic data will be out this week from almost all major Asian economies, including Japan, South Korea and China.
Mark Rourke, Schneider's President and CEO, emphasized that the purchase of Cowan Systems aligns with the company's strategic vision to focus on customer-centric Dedicated solutions. Cowan Systems, ...
Evercore ISI upgraded shares of Zoom Video Communications (NASDAQ:ZM – Free Report) from an in-line rating to an outperform rating in a research report report published on Tuesday, MarketBeat reports.
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.10% of ...
Mark Mahaney, Evercore ISI head of internet research, joins 'Squawk Box' to discuss the latest market trends, state of ...
Fintel reports that on November 26, 2024, Evercore ISI Group upgraded their outlook for Zoom Video Communications ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...
CrowdStrike (CRWD) shares slipped 1% on Monday, even as investment firm Evercore ISI upped its price target on the ...